Peptide Programs
BPC-157
An investigational peptide displayed for demonstration purposes with a strong regulatory disclosure.
$199/month
All-inclusive program price · Illustrative demonstration pricing
Product. Product imagery is an illustrative demonstration mock-up; labels, lots, and concentrations shown are not real.
Peptide Programs
CJC-1295 Program
An investigational peptide listing shown for demonstration only. No muscle, fat-loss, sleep, or anti-aging claims are made.
$199/month
All-inclusive program price · Illustrative demonstration pricing
- Online licensed-provider review
- Secure medical intake after checkout
- Ongoing program support by secure message
- Standard shipping
- Routine follow-up required by the program
Investigational — not FDA-approved
2 mg/vial (illustrative demonstration strength)
Demonstration only. Not available for prescribing or fulfilment pending regulatory review.
Purchasing a program does not guarantee that a prescription will be issued. If the provider does not approve treatment, the order will be handled according to the ClientRx refund and cancellation policy. Laboratory testing, expedited shipping, replacement products, and third-party services are not included unless specifically stated.
Demonstration notice. ClientRx is a fictional demonstration telehealth brand. Products, pricing, providers, pharmacies, and testimonials shown are illustrative only.
About this program
CJC-1295 appears in this demonstration catalogue as an example of an investigational peptide widely marketed online with claims that are not supported by approved human evidence.
CJC-1295 is a growth-hormone-releasing-hormone analogue studied in limited human research. It is not an FDA-approved drug product, and its availability for compounding is restricted.
ClientRx does not promise muscle gain, fat loss, improved sleep, recovery benefits, or anti-aging outcomes. Those are precisely the claims a compliance review should flag when they appear elsewhere.
A real offering would require regulatory clearance, defined clinical governance, documented informed consent, and confirmed pharmacy capability. None of that exists on a demonstration site.
How it may work
As a GHRH analogue, CJC-1295 acts on the pathway governing endogenous growth-hormone release. Mechanism is not the same as demonstrated clinical benefit.
Human data are limited, and endocrine interventions carry meaningful long-term uncertainty.
No dosing or administration information is published.
Safety summary
- The long-term safety profile is not established, and endocrine effects are difficult to predict.
- Reported effects in limited settings include injection-site reactions, flushing, headache, and water retention.
- Material sold online outside regulated channels is of unverified identity, purity, and sterility.
This summary is not a complete list of risks and is not medical advice. Visit the safety center. In an emergency, call 911.
Program questions
ClientRx makes no muscle, body-composition, or performance claims for this product.
Related programs
Longevity and Wellness
Sermorelin
A provider-directed peptide program described in cautious, non-promissory language.
$179/month
All-inclusive program price · Illustrative demonstration pricing
Peptide Programs
Semax
An investigational peptide listing with no neurological or psychiatric treatment claims.
$149/month
All-inclusive program price · Illustrative demonstration pricing